Share Name Share Symbol Market Type Share ISIN Share Description
International Biotechnology Trust LSE:IBT London Ordinary Share GB0004559349 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +4.00p +0.69% 580.00p 576.00p 584.00p 590.00p 576.00p 576.00p 35,633 16:35:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 -1.8 -5.1 - 219.66

International Biotechnology Share Discussion Threads

Showing 326 to 349 of 475 messages
Chat Pages: 19  18  17  16  15  14  13  12  11  10  9  8  Older
DateSubjectAuthorDiscuss
09/4/2014
08:37
Expect this to rise sharply today once NAV announced not too late to top up prior
tokyo sexwhale
08/4/2014
12:59
After being 10% down earlier today BIOG has turned around is is back to near the opening price. Let's hope IBT can follow suit.
snowydays
08/4/2014
11:18
me too , now 24% discount!
rogerrail
08/4/2014
10:57
Nav slightly up on yesterday agree way oversold now have added this morning
tokyo sexwhale
08/4/2014
09:49
Quite a discount; hold quite a lot of these plus BIOG and Tech IT's - most down 25% in a month so my strategy of these investments providing long term growth to sit along boring high income stocks is being put to the test.
philo124
08/4/2014
09:03
way oversold now, NBI index was up 0.5% last night and most of IBT top 10 holdings either up or flat , only 9th largest holding Mylan down singficantly -4.4%, seems to be tracking BIOG not the NBI index, pity it was not tracking it on the way up ! %NBI 2,367.94 +11.34 0.48% 1.BIIB 294.19 +5.92 2.05% 2.GILD 72.23 +0.030 3.REGN 287.19 +1.85 0.65% 4.CELG 139.16 +1.78 1.30% 5.ALXN 145.66 +3.16 2.22% 6.AMGN 118.82 -0.290 -0.24% 7.ILMN 140.46 +1.89 1.36% 8.VRTX 66.40 +0.560 0.85% 9.MYL 48.40 -2.23 -4.40% 10 APTIV n/a IBT 256.50 -14.00 -5.18% BIOG 429.88 -18.62 -4.15
rogerrail
07/4/2014
16:09
not all of them - maybe take a look at PEBI ! m
maurillac
07/4/2014
15:18
Techs and Bios out of favour at the moment.
philo124
07/4/2014
15:15
Discount to NAV now widened to over 18%, this has to be an opportunity to add.
rogerrail
28/3/2014
12:32
NAV is still higher than the peak price in FEB; Date NAV Pence Wednesday 26 Mar Ex Income 349.36
davebowler
26/3/2014
14:00
general weakness in the sector will keep the wide discount for a while yet imo.
pyemckay
26/3/2014
13:52
Dave - Premium/discount has gone from about -5% in early Nov to about -25% now. http://markets.ft.com/research/Markets/Tearsheets/Performance?s=IBT:LSE
trader2
26/3/2014
11:36
Net Asset Values The Board of International Biotechnology Trust plc announces that the unaudited net asset value per share Date NAV Pence Tuesday 25 Mar Ex Income 355.66
davebowler
26/3/2014
11:15
As I type ^NBI off 12% from recent high - IBT off 14%
trader2
26/3/2014
10:48
I think you'll find that falls track back to the row about pricing of Gilead's new hepatitis C drug and whether biotechs can make such prices (USD84000 per patient) stick or whether insurers and govts will decline to buy. Lots of biotech business models are predicated on such high prices....... See http://www.fiercepharma.com/story/politicians-add-fuel-firestorm-over-gileads-hep-c-drug-pricing/2014-03-24
vulgaris
26/3/2014
09:51
Sure getting a good shake!
trader2
24/3/2014
16:49
Yes, the NASDAQ biotech index is falling like a stone. Fears the bubble is bursting. http://uk.finance.yahoo.com/q?s=^NBI
snowydays
24/3/2014
16:44
anyone know why this has dropped so much today?
incar
24/3/2014
13:31
NAV 366 today
tokyo sexwhale
24/3/2014
00:13
Discount has widened since 5th then. NAV 389p share price 330p Now NAV 379p share price 315p
melody9999
06/3/2014
13:20
Date NAV Pence ------------------ ------------ ------- Wednesday 05 Mar Ex Income 389.76
davebowler
27/2/2014
16:42
Holdings RNS.
philo124
26/2/2014
20:28
Bought another 1000 for SIPP.
philo124
26/2/2014
12:05
Daily Funds 26 February 2014 2 Westhouse Securities Trading ideas In the UK, discounts on the lead biotech stocks con tinue to widen, suggesting growing fears that a bubble may be building. However, this does c reate valuation opportunities, with Biotech Growth Trust (BIOG.L, -6.0%) and particularly, International Biotechnology Trust (IBT.L, -19.3%, Buy) increasingly attractive at these levels. It is onl y as recently as May 2013 that the market was willing to attribute a discount of just 2% to IBT, since when the NAV has added a further 29%. NAV performance remains strong and the valuation here now fully reflects growing valuation concerns in relation to the broader biotech sector.
davebowler
Chat Pages: 19  18  17  16  15  14  13  12  11  10  9  8  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180224 08:23:29